DOT1L has also been implicated in hematopoietic malignancies, especially in leukemias harboring Mixed Lineage Leukemia gene (MLL) rearrangements (MLLr, reviewed elsewhere Nguyen and Zhang, 2011; Chen and Armstrong, 2015; Wang et al., 2016). This evidence concerns the gene KMT2A and leukemia.